The Role of Aspartic Acid 143 in E. coli tRNA-Guanine Transglycosylase: Insights from Mutagenesis Studies and Computational Modeling  by Todorov, Katherine Abold et al.
The Role of Aspartic Acid 143 in E. coli tRNA-Guanine Transglycosylase:
Insights from Mutagenesis Studies and Computational Modeling
Katherine Abold Todorov, Xiao-Jian Tan, Susanne T. Nonekowski, George A. Garcia,
and Heather A. Carlson
Department of Medicinal Chemistry, College of Pharmacy, University of Michigan, Ann Arbor, Michigan 48109-1065
ABSTRACT tRNA guanine transglycosylase (TGT) is a tRNA-modifying enzyme which catalyzes the posttranscriptional
exchange of guanine in position 34 of tRNAY,H,N,D with the modiﬁed base queuine in eukaryotes or its precursor, preQ1 base, in
eubacteria. Thus, TGT must recognize the guanine in tRNA and the free base queuine or preQ1 to catalyze this exchange. The
crystal structure of Zymomonas mobilis TGT with preQ1 bound suggests that a key aspartate is critically involved in substrate
recognition. To explore this, a series of site-directed mutants of D143 in Escherichia coli TGT were made and characterized to
investigate heterocyclic substrate recognition. Our data conﬁrm that D143 has signiﬁcant impact on KM of guanine; however, the
trend in the KM data (D143A, D143N, D143S, D143T) is unexpected. Computational studies were used to further elucidate
the interactions between guanine and the D143 mutants. A homology model of E. coli TGT was created, and the role of D143
was investigated by molecular dynamic simulations of guanine bound to the wild-type and D143-mutant TGTs. To validate the
model systems against our kinetic data, free energies of binding were ﬁt using the linear interaction energy (LIE) method. This is
a unique application of the LIE method because the same ligand is bound to several mutant proteins rather than one protein
binding several ligands. The atomic detail gained from the simulations provided a better understanding of the binding afﬁnities of
guanine with the mutant TGTs, revealing that water molecules enter the active site and hydrogen bond to the ligand and
compensate for lost protein-ligand interactions. The trend of binding afﬁnity for wild-type. D143A. D143N. D143S. D143T
appears to be directly related to the degree of hydrogen bonding available to guanine in the binding site.
INTRODUCTION
The modiﬁed base queuine (shown in Fig. 1) is found in the
wobble position 34 of tRNAY,H,N,D which exhibit the anti-
codon sequence GUN, where N represents any base (1). The
queuine modiﬁcation is present in virtually all eubacterial
and eukaryotic organisms (2,3). Almost all modiﬁed bases
are the results of chemical transformations of encoded/
transcribed nucleotides (4); however, pyrrolopyrimidines
like queuine are incorporated via an enzymatic transglycosy-
lation reaction (5). The enzyme tRNA guanine trans-
glycosylase (TGT) catalyzes the incorporation of preQ1
base (7-aminomethyl-7-deazaguanine) into its speciﬁc tRNAs;
it is further modiﬁed in situ to queuine (Fig. 1). In eukaryotic
organisms, TGT incorporates queuine directly.
The tgt gene is found in many disease-causing bacteria
including Helicobacter pylori, bacteria suspected to cause
stomach cancer (6), and Shigella ﬂexneri, bacteria which
cause Shigellosis or ‘‘bacillary dysentery’’. The Escherichia
coli tgt gene is homologous (.98% sequence identity) to the
pathogenic vacC gene, which is known to be partially re-
sponsible for the virulent phenotype of S. ﬂexneri. This has
been demonstrated by the observation that an inactive vacC/
tgt mutant exhibits a decrease in pathogenicity that is likely
due to a decrease in bacterial invasion (7). Thus, TGT has
become a novel target for antishigellosis therapy and possibly
broad-spectrum antibiotics. The rational design of TGT
inhibitors is an ongoing effort (8–11), and understanding the
molecular recognition of substrates and inhibitors is im-
portant to these efforts.
Several key residues have been implicated as having vital
roles in TGT activity due to their conservation in TGTs
across species and kingdoms. Speciﬁcally, there are three
aspartate residues in the TGT active site that are absolutely
conserved among TGTs across all three kingdoms. Two of
the aspartates (D89 and D264, E. coli TGT numbering) have
been implicated in catalysis. TGT has been shown to go
through a covalent enzyme-RNA intermediate, with one of
the aspartates (initially thought to be D89 but now shown to
be D264) acting as the enzymic nucleophile and the other
aspartate (D89) acting as a general base (12–15). The third
aspartate (D143) has been proposed to be involved in
heterocyclic substrate recognition (16).
The crystal structure of preQ1 bound to the Zymomonas
mobilis TGT (16) reveals that D156 (equivalent of D143 in
E. coli TGT) interacts with preQ1 through hydrogen bonds to
N-3 and the exocyclic amino group at C-2 (Fig. 2 A). The
ping-pong kinetic mechanism of TGT (17) dictates that the
wobble guanine of tRNA is bound in the preQ1 binding
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pocket, removed, and replaced with preQ1. As such, the
same active-site residues could be vital for recognizing
guanine by making similar hydrogen-bonding contacts.
Romier et al. made two mutants of the equivalent of D143
in the Z. mobilis TGT (14). They found that both the alanine
and tyrosine mutants were inactive. The crystal structures
revealed that there was no change in the tertiary structure,
ruling out a gross structural change as the cause of inactivity.
Thus, the only experimental evidence to support a speciﬁc
role in heterocyclic substrate recognition for D143 is the
observation that these two mutants were inactive under the
experimental conditions tested. However, these data are also
consistent with a number of other roles for D143 (e.g.,
participation in catalysis, electrostatic stabilization of the
transition state, or altered tRNA binding).
To more fully elucidate the role of D143 in the TGT
reaction, this study has generated and characterized a series
of mutants: D143A, D143N, D143S, and D143T. (We did
not pursue the D143Y mutant because its inactivity appears
to simply come from the increased steric bulk blocking the
substrate’s access to the active site.) Our four mutants were
designed to probe various aspects of the hydrogen-bonding
interactions of D143 with the heterocyclic substrate. Our
data show that the mutants do not signiﬁcantly alter the KM
of tRNA and have only a minor effect on kcat—ruling out
D143 being signiﬁcant in the binding of tRNA or the rate-
limiting catalytic step. Instead, KM data for guanine show
that D143 directly inﬂuences the binding of heterocycles.
However, we were surprised to ﬁnd that the D143A
mutant had the greatest afﬁnity for guanine. The D143N
mutant was expected to have the highest afﬁnity for guanine,
given its similarity to D143. Obviously, the activity of
D143A points to a subtle and complex relationship. To
interpret the trends observed in the experimental data,
substrate recognition at the atomic level was explored with
computer simulations. To achieve this, homology models of
E. coli wild-type (wt) and D143-mutant TGTs were created
based on the crystal structure of the Z. mobilis TGT (16). The
models were then subjected to molecular dynamics (MD)
simulations and free energy calculations using the linear
FIGURE 2 Comparison of the active sites of Z. mobilis TGT and our homology model of E. coli TGT. Structures are colored by atom type; the Z. mobilis
structure has green carbon atoms, and the E. coli homology model has gray carbons. (A) The hydrogen-bonding pattern is given for the 2.2-A˚ crystal structure
of Z. mobilis TGT with preQ11 bound. (B) The fully energy-minimized homology model of E. coli TGT with preQ
1
1 is compared to the Z. mobilis crystal
structure used in its creation. In the E. coli structure, bridging waters, the residues equivalent to Z. mobilis C158 and M260, and hydrogen atoms are not shown
for clarity. The crystallographic waters and the cystiene and methionine residues were retained in the creation of the homology model, and their ﬁnal positions
were very similar to their initial locations.
FIGURE 1 Biosynthesis of queuine-tRNA in eubacteria.
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interaction energy (LIE) method (18,19). Our models of the
TGT system have assisted in the interpretation of the exper-
imental data by providing details about the atomic inter-
actions between the substrate (guanine) and enzymes (wt TGT
and its D143 mutants).
METHODS
Determination of steady-state kinetic parameters
for guanine and tRNA
His-tagged wt and mutant TGTs (htTGT(wt), htTGT(D143N), htTGT
(D143T), htTGT(D143S), and htTGT(D143A)) were generated, expressed,
and puriﬁed using standard techniques andmaterials (12) which are described
in full detail in the Supplementary Material. Steady-state kinetic parameters
(KM and kcat) for guanine and tRNA were determined for htTGT(wt) and the
mutants using methodology previously described (20). The assays were
performed, at least, in triplicate. htTGT (10 nM for wt and 50 nM for mutants)
was incubated with various concentrations of tRNA and [3H]-guanine in the
presence of MgCl2 (20 mM), DTT (5 mM), and HEPES, pH 7.3 (100 mM) in
a total reaction volume of 400 mL. At varying intervals over an appropriate
time course of 2–10 min or 15–120 min (longer time course for less active
mutants), 70mL aliquots were withdrawn and quenched in 2 mL of 5% TCA.
The precipitated tRNA was then collected on Whatman GF/C ﬁlters. The
ﬁlters were dried and counted via liquid scintillation. Initial velocities were
obtained from linear regression of plots of pmol guanine (calculated from the
measuredDPM, the aliquot size, and the speciﬁc activity of the guanine used)
incorporated versus time. The various enzyme concentrations were in-
corporated into the calculations, and concentrations of substrates were
individually varied to obtain sets of initial velocities. To determine the
guanine kinetic parameters for wt and all mutants, the tRNA concentration
was held ﬁxed at 20 mM. The guanine concentration ranges were: 0.05–20
mM, 0.25–250 mM, or 5–1000 mM depending on the mutant. To determine
the tRNA kinetic parameters, the tRNA concentrations ranged from 0.1 to 40
mM with guanine ﬁxed at 10 times its KM for the particular mutant. Due to
the lower speciﬁc activities of the TGT mutants, their time courses were
lengthened to 120 min (15, 30, 60, 90, and 120 min intervals), and the
concentrations of enzymeswere increased to 50 nM. The initial velocitieswere
plotted against the concentration of the varied substrate. Kinetic parameters
(KM and kcat) were calculated from a nonlinear ﬁt of the initial velocity data to
theMichaelis-Menten equation.All kinetic parameters are calculated from the
average of three replicate determinations of initial velocity data. All relative
values were determined relative to htTGT(wt). The standard deviation within
each point was calculated and is represented graphically by an error bar over
each point in the data plots (21,22). The errors for the ﬁtted parameters are
standard errors of the ﬁts (23).
Generation of the homology model of E. coli TGT
Additional parameters were required to model our heterocycles with the
Amber94 force ﬁeld (24). It was straightforward to generate these param-
eters using techniques outlined in the literature. The parameters and the com-
plete details of their creation are provided in the Supplementary Material.
An alignment of Z. mobilis TGT and E. coli TGT sequences is provided
in the Supplementary Material. There is 56% sequence identity and 68%
sequence similarity between the two bacterial TGTs. The molecular
modeling program MOE (25) was used to build the homology model of
E. coli TGT with preQ11 bound. A 2.2-A˚ crystal structure of Z. mobilis TGT
with preQ11 bound (R. Ficner, personal communication of coordinates,
University of Marburg, Germany), was used as the basis for our E. coli
model. Two short, unresolved loop regions (residues 99–106 and 115–124)
were taken from the 1.8-A˚, unbound structure of Z. mobilis TGT (Protein
Data Bank (pdb) code 1PUD) (16,26). A three-residue deletion in the
backbone (residues 190–192, Z. mobilis TGT numbering) was made at the
end of a helical region exposed to solvent. Due to potential structural roles,
all buried water molecules were kept.
The side chains in the Z. mobilis TGT structure were then altered to match
the E. coli sequence starting at the binding site and working outward in
successive shells retaining all common atom positions. Each new residue
was manually checked for optimal hydrogen-bonding and electrostatic
interactions. Ionization states of all ionizable groups were veriﬁed with pKa
calculations (27–29) using UHBD (30). No unusual ionization states were
determined for typical acidic or basic side chains. All histidines were
determined to be neutral, and the three cystienes that coordinate the zinc ion
were determined to be deprotonated as expected. Both ends of the protein
were capped because the E. coli TGT C-terminus is longer than the Z.
mobilis TGT, and experimentally the E. coli TGT N-terminus is appended
with a HisTag. First the hydrogen atoms then the side chains of the E. coli
TGT structure were energy minimized using the Amber94 force ﬁeld within
MOE (with our added parameters for preQ11 ). Finally, the backbone was
allowed to relax in the altered loop areas. The minimization protocol
consisted of steepest descent steps to a root mean-square gradient of 10 kcal/
molA˚, conjugate gradient steps to a gradient of 1 kcal/molA˚, and 200
truncated-Newton steps or a convergence of 0.001 kcal/molA˚. Coordinates
for the wt homology model are provided in the Supplementary Material.
MD simulations
All MD simulations and energy analyses were conducted using the Amber94
force ﬁeld (24) and Sander_Classic from the AMBER6 (31,32) suite of
programs. The nonbonded pair lists were updated every 20 steps. The van
der Waals energies were truncated at a 10.0 A˚ distance; the electrostatic
energies were truncated at 17.0 A˚. The 1–4 electrostatic interactions and the
1–4 van der Waals interactions were divided by the scaling factors 1.2 and
2.0, respectively. PreQ11 was replaced with guanine, and the homology
model of E. coli TGT was hydrated with a 31-A˚ sphere of water centered on
the bound ligand. The simulation of unbound guanine was also solvated in
a 31-A˚ sphere of water. The chosen protocol followed appropriate standards
in the ﬁeld. Additional details are provided in the Supplementary Material
for completeness.
The systems (wt TGT with guanine bound and guanine alone in solution)
were equilibrated for 150 ps at a temperature of 310 K. At this point, the
equilibrated wt TGT—with the altered loops relaxed and the active site
adjusted to accommodate guanine—was modiﬁed to create mutant-TGT
systems (residue D143 altered while conserving any analogous atomic
positions). An additional 150 ps of equilibration was completed for the new
mutant-D143 systems. After equilibration, 1 ns of sampling was completed
with coordinates saved every 1.0 ps for structural and energetic analyses.
Hydrogen-bonding analyses were carried out with AMBER’s CARNAL pro-
gram. Additional in-house codes were used to analyze bridging water mo-
lecules by measuring the distances and angles to deﬁne multiple hydrogen
bonds. The required distance for a hydrogen bond was 3.5 A˚ or shorter
between the heavy atoms (3.7 A˚ or less for hydrogen bonds involving sulfur
atoms). The X-H-Y angles were required to be 120–180.
Free energies calculated using the LIE method
The LIE method (Eq. 1), developed by A˚qvist and coworkers (18), samples
the ligand in explicit solvent alone and bound to protein. Free energies are
then estimated by a comparison of the energetics of the ligand in those two
environments. The interactions between the ligand and its environment
(either pure solvent or protein with solvent) are divided into electrostatic
(DGelec) and van der Waals (DGvdw) components. The binding free energy
(DGbind) is estimated as
DGbind ¼ DGelec1DGvdw ﬃ 1
2
ðÆEelecæbound  ÆEelecæfreeÞ
1aðÆEvdwæbound  ÆEvdwæfreeÞ; (1)
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where ÆEelecæ and ÆEvdwæ are the average electrostatic and van der Waals
interaction energies of the ligand with its environment, and the bound and
free subscripts refer to simulations of the ligand bound to the protein or alone
in explicit solvent, respectively. Each energetic value is an average taken
from the ensemble of conﬁgurations generated byMD. In Eq. 1, the electrostatic
scaling factor of 1/2 is a standard value derived from statistical mechanics.
The van der Waals scaling factor, a, is dependent on the protein system;
other groups have reported values ranging from 0.1 to 1.2 for various protein
systems (18,19,33–43).
The electrostatic and van der Waals energies of the ligand with its
environment were provided by Sander_Classic (which we modiﬁed to print
the necessary energetic components). The values were determined for each
MD snapshot, and the energetic components were averaged to obtain Eelec
and Evdw for both bound and free systems.
The binding free energy (DGbind) was estimated using the LIE method
(Eq. 1). It is necessary to determine an appropriate value for a based on the
experimental data for guanine and TGT (wt, D143A, D143N, D143S, and
D143T). The average energies were RMS ﬁt to the experimental data to
determine the most appropriate value for a. Below, the reasonable value for
a and the accurate trend in DGbind indicate that the simulations and meth-
odology are appropriate to provide insight into this system.
RESULTS AND DISCUSSION
Determination of steady-state kinetic parameters
for guanine and tRNA
A series of D143-mutants of TGT was generated to in-
vestigate the role of this residue, postulated to involve het-
erocyclic substrate recognition. The various mutations were
designed to probe the hydrogen-bonding contacts between
this residue and the N-3 and the exocyclic amine at C-2 of the
heterocyclic substrate. The htTGT(D143N) mutation re-
moves one hydrogen-bond acceptor (substituting it with a
potential hydrogen-bond donor, the amide nitrogen). The
htTGT(D143T) mutation also removes one hydrogen-bond
acceptor and displaces the remaining hydrogen-bond acceptor
(also a possible donor) by one methylene group but incor-
porates some potential van der Waals contacts via the methyl
group. The htTGT(D143S) mutation has the same hydrogen-
bonding capability as the threonine mutant but lacks the
potential van der Waals contacts of the methyl group. Lastly,
the htTGT(D143A) mutation removes the possibility for any
hydrogen bonds, and its small size provides little, if any, van
der Waals contacts.
The mutant TGTs (except for D143T) were originally
constructed and found to overexpress only in the presence of
chromosomally encoded, wt TGT. This strongly suggests
a signiﬁcant role for D143. It is attractive to speculate that if
D143 is involved in heterocyclic substrate recognition, then
the mutants may allow ‘‘incorrect’’ bases to be incorporated
into the TGT-substrate tRNAs. This would result in tRNAs
with altered anticodons, leading to loss of ﬁdelity during
translation at the ribosome and, ultimately, cell death. The
presence of the higher-activity, wt TGT would ‘‘protect’’ the
tRNAs by correctly modifying them and doing so more eff-
iciently than the mutants with their poorer catalytic activity.
The kinetic parameters for all TGTs have been determined
for tRNA (Table 1) and for guanine (Table 2) using the
guanine exchange assay. htTGT(wt) shows kinetic param-
eters comparable (within a factor of 2–3) to those of wt TGT
(Tables 1 and 2), indicating that the HisTag does not signif-
icantly perturb TGT activity. The hyperbolic plots obtained
from ﬁtting the initial velocity data versus substrate
concentration to the Michaelis-Menten equation are shown
in Fig. 3 for htTGT(wt), htTGT(D143A), htTGT(D143N),
htTGT(D143S), and htTGT(D143T). On each plot is an inset
of the low concentration range to better depict visually how
well the data ﬁt to the Michaelis-Menten equation.
A direct role for D143 in catalysis would predict a large
decrease in kcat values for the D143 mutants; however, only
a 4- to 16-fold reduction in kcat is observed compared to
htTGT(wt). In contrast, the kcat values of TGT(D89) mutants
are reduced ;100- to 1000-fold compared to wt (12). Addi-
tionally the kcat values for all D143 mutants are almost
identical to one another. This modest and consistent decrease
in activity suggests that the mutations are not directly affec-
ting catalysis. It is possible that some indirect effects may be
responsible for this small effect on catalysis (further dis-
cussion below).
A signiﬁcant role for D143 in binding tRNA would predict
a change in KM for tRNA in the D143 mutants relative to wt;
however, this also is not observed. In fact, the KM values for
tRNA are very similar (;1.5- to 3-fold different) for the
mutants relative to wt, with a range of KM values from 0.6–
1.9 mM. Our current models of the kinetic (17) and chemical
TABLE 1 Table of tRNA kinetic parameters for TGTs
Enzyme kcat*
yz (103s1) KM*
yz (mM) kcat/KM*
yz (103s1mM1) Relative KM*
z§ Relative kcat/KM*
z§
TGT(wt){ 5.2 (0.3) 0.19 (0.05) 27 (7) – –
htTGT(wt) 3.10 (0.09) 0.60 (0.09) 5.1 (0.8) 1.0 1.0
htTGT(D143A) 0.36 (0.18) 0.83 (0.08) 0.43 (0.22) 1.4 0.084
htTGT(D143N) 0.56 (0.02) 1.5 (0.3) 0.36 (0.06) 2.6 0.071
htTGT(D143S) 0.27 (0.01) 1.9 (0.3) 0.15 (0.02) 3.2 0.029
htTGT(D143T) 0.20 (0.02) 1.8 (0.3) 0.11 (0.02) 3.0 0.022
*Errors are shown in parentheses.
yKinetic parameters are calculated from the average of three replicate determinations of initial velocity data.
zError was calculated as detailed in the methodology and referenced in Gordon and Ford (21) and Harris (22).
§Relative values were determined relative to that of His-tagged wt.
{TGT (wt) data were taken from Goodenough-Lashua (54).
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mechanisms (12,13) for TGT suggest that D143 interacts
with G-34 of tRNA. However, given the number of
interactions that must exist in the interface between tRNA
and TGT, it is reasonable to ﬁnd that changes in the D143-G-
34(tRNA) interaction have a minimal effect on the KM of the
whole tRNA.
The greatest impact that the mutations have on the kinetics
of the TGT reaction involves theKM of guanine. An;75-fold
increase (relative to wt) is observed in the KM value for
htTGT(D143A); a 150-fold for htTGT(D143N); a 380-fold
increase for htTGT(D143S) and a 700-fold increase for
htTGT(D143T) is seen. A similar, but decreasing, trend for
kcat/KM is seen for the mutants; however, the magnitude is
larger with a range for the mutants of 450- to 8300-fold
decrease in kcat/KM relative to wt. The slight and consistent
decrease in kcat (10-fold) for the mutants indicates that this
decreasing trend in catalytic efﬁciency (kcat/KM) is due almost
exclusively to the increase in KM for guanine. It should be
noted that, in general, KM is not a true dissociation constant.
As mentioned above, the kinetic mechanism for TGT-
catalyzed guanine exchange is ping-pong, with tRNA bind-
ing ﬁrst. However, it is very likely that the rate-limiting step
occurs after guanine binds to the TGT-tRNA covalent inter-
mediate (44). If this is the case, then the KM values reported
here for guanine should closely approximate (if not equal) the
dissociation constants for guanine and can be treated as such.
The dramatic change in KM values for guanine upon
mutating D143 supports the hypothesis that its primary role
is the recognition of heterocycles in the catalytic site. It was
reasonable to assume that the KM values for guanine would
have increased in this order: wt , D143N , D143T ,
D143S , D143A due to each protein’s potential for forming
hydrogen bonds with guanine. However, the results yield an
overall trend in guanine KM of wt , D143A , D143N ,
D143S , D143T. We observe a similar trend in decreasing
catalytic efﬁciency (kcat/KM). The fact that htTGT(D143A)
has a lower guanine KM value than the other mutants seems
counterintuitive. Mutation of aspartate to alanine removes
the possibility of any hydrogen bonds between residue 143
and the heterocyclic substrate, whereas at least one potential
hydrogen bond remains with each of the other mutants. To
explore the possible causes of the unexpected trend, we used
MD simulations to provide atomic details of the recognition
between guanine and each TGT system.
Simulating the guanine-TGT system
The eubacterial TGT is a bisubstrate enzyme, binding both
tRNA and a heterocycle. The experimental binding data were
determined in the presence of tRNA. However, no crystal
structures existed for TGT bound to RNA until after our
calculations were complete. The ﬁrst and only cocrystal
structure was an RNA minihelix covalently attached to the Z.
mobilis TGT (15). Still, no crystal structures exist of a full
tRNA bound to any TGT, and no crystal structures exist for
any E. coli TGT systems.
For our calculations, docking tRNA (and its many
counterions) to TGT to create a TGTtRNA complex would
have introduced too much uncertainty into our models. We
chose to study TGT and the heterocycle without bound
tRNA. Though this is a simpliﬁcation of the real system, the
point of this study is to clarify the role of D143, and it
appears that tRNA is not a signiﬁcant factor for D143 for
several reasons.
First, the structure was unchanged by binding RNA (15).
The crystal structure of Z. mobilis TGT bound with the RNA
minihelix clearly indicates that no structural changes occur in
the active site of TGT upon RNA binding.
Second, residue 143 most likely has the same interactions
to the heterocycle with or without tRNA. In the preQ11  TGT
structure (16), D143 binds to the aminopyrimidone portion
of preQ11 at a point that is distal to where the body of the
tRNA is likely to bind.
Third, the interaction of tRNA with TGTheterocycle is
expected to be the same for all mutants. This is supported by
the observation that residue D143 seems to have very little
overall effect on the binding of tRNA (evidenced by the KM
values of D143 mutants with tRNA in Table 1). Because the
interaction of RNA with all TGTs is the same, leaving the
tRNA out of the model is a constant, systematic simpliﬁca-
tion. If the simpliﬁcation is consistent across all the simu-
lations, the LIE methodology can correct for the missing
TABLE 2 Table of guanine kinetic parameters for TGTs
Enzyme kcat*
yz (103s1) KM*
yz (mM) kcat/KM*
yz (103s1mM1) Relative KM*
z§ Relative kcat/KM*
z§
TGT(wt){ 6.3 (0.1) 0.35 (0.03) 18 (2) – –
htTGT(wt) 2.3 (0.1) 0.15 (0.02) 16 (2) 1.0 1.0
htTGT(D143A) 0.38 (0.01) 11 (1) 0.033 (0.003) 75 0.0022
htTGT(D143N) 0.58 (0.02) 22 (3) 0.027 (0.003) 145 0.0017
htTGT(D143S) 0.25 (0.01) 57 (8) 0.0044 (0.0007) 380 0.00028
htTGT(D143T) 0.20 (0.01) 105 (22) 0.0019 (0.0004) 700 0.00012
*Errors are shown in parentheses.
yKinetic parameters are calculated from the average of three replicate determinations of initial velocity data.
zError was calculated as detailed in the methodology and referenced in Gordon and Ford (21) and Harris (22).
§Relative values were determined relative to that of His-tagged wt.
{TGT (wt) data were taken from Goodenough-Lashua (54).
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tRNA in the free energy calculations. The systematic error is
compensated by the ﬁtting of a for the system.
Lastly, these calculations were done in close collaboration
with the experimental studies. The agreement between the
experimental and computational data supports our models.
Without the consistency of the data and the collaboration
between the research groups, developing simpliﬁed and
reliable models would have been too risky.
The LIE method is also appealing because it is 5–10 times
faster than free energy perturbation calculations (35).
Though LIE is less accurate than free energy perturbation,
it still accounts for the ﬂexibility of proteins by employing
either MD or Monte Carlo sampling. LIE also incorporates
the unbound state of the ligand to account for binding
penalties such as desolvation. This makes the LIE method
attractive for our studies and structure-based drug design
(33–35). It should be noted that generalized Born/surface
area and Poisson-Boltzmann/surface area methods are also
popular for estimating binding free energies (39,45–48), but
they are computationally more expensive and no more
accurate than LIE. They cannot be used in this study
because the missing tRNA would greatly alter the
electrostatics calculations at the heart of those methods,
and there is no way that we can compensate for the missing
tRNA as we can with LIE. Furthermore, these methods
require estimates of the entropic contributions based on
normal mode analysis, but these will also be incorrect
without tRNA.
FIGURE 3 Wt and D143-mutant TGT data
ﬁt to Michaelis-Menten kinetics. (Left) tRNA.
(Right) Guanine. Curves were obtained from
the average of three independent determina-
tions of initial velocity data. Error bars are
generated from the standard deviation in each
point. The insets are expansions of the low
concentration ranges.
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Reliability of the homology model
A homology model of E. coli TGT was created to answer key
recognition questions involving residue D143. The 2.2-A˚
crystal structure of Z. mobilis TGT with preQ11 bound was
used as the starting structure for the homology model. The
sequence alignment given in the Supplementary Material
shows that the Z. mobilis structure is a good basis for the
E. coli model. Also, the reliability of the resulting homology
model is highlighted by its structural similarity to related
systems. Fig. 2 B shows the similarity of the active sites of the
Z. mobilis TGTpreQ11 complex and the fully energy-
minimized homology model of E. coli TGT with preQ11
bound (the model before solvation and changing the ligand to
guanine). Only a slight shift in the location of preQ11 is seen,
and the homologymodel is in good agreementwith the crystal
structure used in its creation. It is also similar to another
related structure; Xie et al. were able to soak 9-deazaguanine
into a Z. mobilis TGT complex (15). The aspartate that cor-
responds to D143makes the same two key hydrogen bonds to
9-deazaguanine that are seen in the preQ11  TGT structure
and the homology model.
It is interesting to note that our model of wt E. coli TGT
binding guanine shows similar hydrogen bonds to those
that are seen in an archaeosine TGT crystal structure (49),
providing a second independent validation that the simu-
lations are accurate. A crystal structure of an archaeal TGT
with guanine bound shows that the D130 (analogous to D143
in E. coli TGT) makes two hydrogen bonds with N-1 and the
exocyclic amine of guanine; Q196 (analogous to Q187 in
E. coli TGT) and G214 (as opposed to C145 in E. coli TGT)
are also within hydrogen-bonding distance to the oxygen of
guanine. Possible base stacking of guanine with F93 is also
seen. A common hydrogen-bonding pattern is expected due
to the conservation of key active-site residues which are
presumably responsible for binding the common substrate.
Temperature, total energy, total potential energy, and
potential energy components (electrostatic and van der
Waals energies) showed that all ﬁve systems were fully
equilibrated after 150 ps of sampling at 310 K. The
following 1-ns sampling phase generated ensembles of
conformations from which structural and energetic analyses
were performed. Structural analyses of the protein con-
formations obtained from each picosecond of the protein-
ligand simulations showed no marked difference to their
initial structures. Of course, regions of the system $24 A˚
from the center of guanine were restrained because of our use
of a 31-A˚ sphere of water to solvate the system. However,
the average RMSD of the mobile region of the protein was
modest and appropriate, only 1.05 A˚ from its starting
structure. Furthermore, the modiﬁed loop regions, which
were fully ﬂexible in the simulation and the most likely to
exhibit altered structure, did not change signiﬁcantly. This
indicates stable homology models and properly executed
MD simulations.
FIGURE 3 Continued.
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Energy analysis and free energies of binding
Sander_Classic was modiﬁed to report the energy compo-
nents between the ligand and its environment. Table 3 shows
the average values for electrostatic and van der Waals ener-
gies for guanine interacting with TGT and water. Because all
binding events are in equilibrium with an unbound state, the
energies from the MD simulations of the unbound ligand
must be subtracted from the energies in the bound state in
the LIE methodology (Eq. 1). These values are also given in
Table 3. To show the convergence of these values, plots of
Evdw, Eelec, ÆEvdwæ, and ÆEelecæ versus time are provided in the
Supplementary Material.
There are very few experimentally determined binding
constants for TGT due to the nature of the experimental assay
system and the difﬁculty in obtaining radio-labeled substrates.
As discussed above, the kinetic mechanism for TGT and other
observations strongly suggest that the KM for guanine closely
approximates, and may actually be equal to, the dissociation
constant for guanine. Therefore, the experimentally measured
KM values of guanine with TGT (wt and D143 mutants) were
used to estimate KA in determining an experimental value for
DGbind for each system (Table 4). Ana value of 0.55 (6 0.04)
was obtained by an RMS ﬁt to the experimental data for all
ﬁve TGT systems. The experimentally ﬁt scaling factor
provided the calculated free energies of binding (Table 4).
Plots showing the convergence of DGbind over the MD
simulations are provided in Supplementary Material. The
later halves of the MD simulations show little drift (,1 kcal/
mol) in the calculated values.
The experimental values for DGbind were well reproduced,
which helps validate the appropriateness of the model, the
stability of the MD simulations, and the ﬁt of the scaling
factor a. The order of DGbind is correct except for D143T,
and given the small range in free energies of binding, this
agreement is very good. Also, the low activity of the D143S
and D143T mutants resulted in larger errors in their KM
values (;20% for D143T), so reproducing these values is
expected to be more difﬁcult.
Given that the calculated free energies are in good agree-
ment with the experimental data, it would appear that the
LIE method was capable of compensating for the simpliﬁ-
cation of the computational model. The value of 0.55 for a is
well within the range of the values reported in the literature
(0.1–1.2). An unusual value was not necessary to compen-
sate for the omission of tRNA in the model. This homology
model should be useful and accurate for examining the mo-
lecular recognition of similar heterocycles to TGT and the
D143-mutant TGTs.
Structural analysis of wt and mutant TGTs
Hydrogen bonds are an important aspect of recognition
between TGT and its ligands. Fig. 4 depicts the hydrogen-
bonding schemes observed for guanine with wt and D143-
mutant TGTs. Because wt TGT is proposed to recognize
both guanine and preQ11 in the same site, it is interesting to
compare the hydrogen-bonding patterns of guanine bound to
wt in Fig. 4 to preQ11 bound to wt in Fig. 2 B. The major
difference between preQ11 and guanine is the charged amino-
methyl group of preQ11 . During the MD, the smaller guanine
ligand has shifted deeper into the active site of wt TGT,
placing the ﬁve-membered ring into the region occupied by
the amino-methyl group of preQ11 . This provides a slightly
different hydrogen-bonding pattern. The shift moves gua-
nine away from its van der Waals contact with the side chain
of M244, but this allows the backbone of M244 to accept
a hydrogen bond from guanine in the wt simulation. Also,
the hydrogen bond made by the backbone of G214 in initial
homology model was replaced by a partial hydrogen bond
from the C145 side chain in the MD (Wild type in
Fig. 4, but it should be noted that all of the D143 mutants
exhibit a hydrogen bond between G214 and guanine).
To understand the differences in binding between the wt
and mutant TGT, it is important to compare the patterns of
molecular recognition. Table 3 shows that the major dif-
ference between the wt and D143-mutant TGTs is the
electrostatic interaction energy. The strong electrostatics
comes from the hydrogen bonds between guanine and the
charged side chain of D143. The complementarity is very
speciﬁc and tight. This is also obvious in the MD because the
conformational sampling of guanine within the binding site
is limited (data not shown).
TABLE 3 Energy components of guanine interacting with
TGTs, in kcal/mol
Enzyme ÆEelecæbound
* ÆEvdwæbound
*
ÆEelecæbound
ÆEelecæfree
y
ÆEvdwæbound
ÆEvdwæfree
z
Wild-type 57.0 22.7 7.4 11.8
D143A 47.7 24.1 1.9 13.2
D143N 48.4 23.1 1.2 12.2
D143S 47.7 23.2 1.9 12.3
D143T 47.9 23.7 1.7 12.8
*Energies are an average of 1000 energies taken from the sampling run.
yThe average electrostatic energy of free ligand in water is 49.6 kcal/mol.
zThe average van der Waals energy of free ligand in water is 10.9 kcal/
mol.
TABLE 4 Comparison of experimental and LIE free energies of
guanine of binding to TGTs
Enzyme
Experimental*
DGbind (kcal/mol)
Calculatedy DGbind
(kcal/mol)
Difference in
DGbind (kcal/mol)
Wild-type 9.7 10.2 0.5
D143A 7.0 6.3 0.7
D143N 6.6 6.1 0.5
D143S 6.0 5.8 0.2
D143T 5.6 6.2 0.6
*DGbind ¼ –RT (ln KA), where KA is estimated as equal to (KM)1 as
reported in Table 2.
yBased on Eq. 1, the energies in Table 3, and a van der Waals scaling
factor, a, of 0.55 (60.04).
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The similarity in the experimental free energies of binding
in Table 4 implied that the differences between the mutants
would be more subtle. Table 3 conﬁrms this because the
energy components for all mutants fall within a 1 kcal/mol
range. Our greatest interest was to explain the unexpected
KM trend—why did the D143A mutant have the tightest
binding afﬁnity? We were surprised to ﬁnd an elaborate
network of water molecules that bridge between the binding
site and the guanine ligand (Fig. 4). The D143A simulation
has more bridging waters than what is seen in Fig. 2 A, but
several positions are similar. Another similarity to Fig. 2 A is
the fact that D89, S90, and D264 are important in orienting
the bridging water in many of the mutants. Table 5 shows
that the water molecules actually permit the D143A mutant
to provide the most hydrogen bonds to complement guanine.
This network was highly mobile with several exchanging
water molecules that continued to provide the same large
number of hydrogen bonds to guanine. Water has also been
seen to compensate for a mutation of aspartate to asparagine
in hypoxanthine phosphoribosyl transferase (HPRT) (50).
TABLE 5 Number of hydrogen bonds between guanine and the TGT binding sites
Ligand-protein hydrogen bonds Water-mediated hydrogen bonds Total hydrogen bonds
Experimental DGbind
(kcal/mol)Enzyme Full Partial Full Partial Full Partial
Wild-type 4 1 0 1 4 2 9.7
D143A 2 2 2 2 4 4 7.0
D143N 1 3 3 0 4 3 6.6
D143S 2 1 2 2 4 3 6.0
D143T 2 0 2 2 4 2 5.6
FIGURE 4 Hydrogen-bonding schemes for guanine bound to wt and D143-mutant TGTs. Distances are given in A˚ngstroms. Interactions shown in black are
observed in 72–100% of the snapshots from the MD; interactions in gray are observed in 40–67% of the snapshots. Details of the occupancy for each
interaction are given in the Supplementary Material.
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Crystal structures of the HPRT mutant D137N reveal that
several water molecules mediated hydrogen bonds between
the ligand and the protein side chains.
Table 5 also shows that the number of hydrogen bonds
for the mutants parallel the experimental free energies of
binding. As one would expect, a greater number of hydrogen
bonds by the side chains and bridging water molecules
provides a tighter complement and stronger free energies of
binding (D143A . D143N . D143S . D143T). Though
the calculated free energy of binding is out of order for
D143T in Table 4, the patterns observed in the MD parallel
the experimental data. The hydrogen-bonding pattern seen
for D143T shows the least number of hydrogen bonds—
providing little water-mediated rescue of recognition—
appropriate for D143T having the poorest KM. Also, the
movement of guanine in the binding site during the MD is
signiﬁcant, showing poor complementarity (data not shown).
As mentioned earlier, the larger error in the KM values for
D143T may explain why its calculated free energy of binding
is out of order.
Additional patterns in the simulations of all mutant TGTs
may also explain part of their reduced binding afﬁnity for
guanine. In the original Z. mobilis structure and E. coli
homology model with preQ11 , D143 and S90 are;4 A˚ apart
and do not share a hydrogen bond, but the simulations
revealed an important secondary role for D143 and S90. In
the simulations of wt E. coli TGT with guanine, S90 and
D143 make a strong hydrogen bond (average O-O distance
of 2.7 A˚ and average O-H-O angle of 175.8 between the
hydroxyl group of S90 and the carboxylate group of D143).
In the mutants, loosing the aspartate removes this hydrogen
bond and causes S90 to adopt a conformation away from
residue 143 (moving;2 A˚, Fig. 5) to a position more similar
to that seen in the Z. mobilis crystal structure. Others have
proposed that S90 is used to orient the substrate (11,51), but
the distance observed between the ligand and S90 in the
simulations and the crystal structure is too long for a proper
hydrogen bond. In the farther position seen in the MD of the
mutants, S90 is able to coordinate bridging water molecules
to complex guanine as noted above.
In the mutants, changes are also seen in D264 and M244-
V246. D264 twists 90. The twist helps D264 and neigh-
boring Y242 to interact with bridging water in the binding
site. D264 and Y242 play a direct role with bridging water in
the D143A and D143N simulations, respectively (Fig. 4).
Also, D264 is known to orient bridging water molecules in
crystal structures of Z. mobilis TGT (13). Although water
bridging between D264 and the heterocycle is interesting, it
should be noted that D264 performs a nucleophilic attack
during catalysis. This is its primary function, and we do not
want to overemphasize any role it may play in the recogni-
tion of guanine.
The reorientation of D264 breaks its hydrogen bond with
the backbone of G245 that is seen in the wt simulation
(important for D264 to be available for the nucleophilic
attack). G245 moves, but more importantly, this changes the
positions of neighboring M244 and V246 (Fig. 5). M244
moves ;1.5 A˚. This breaks the hydrogen bond between
guanine and the backbone of M244, and instead, there is an
interaction between guanine and the side chain in a van der
Waals, sulfur-aromatic interaction only seen in the mutants
(or in the wt binding preQ11 ). V246 ﬂips its side chain
signiﬁcantly, and this makes A216 and V217 move down to
ﬁll missing van der Waals interactions. This change in the
shape of the pocket due to A216, V217, V246, and M244
may account for the slightly greater van der Waals interac-
tion energies in the mutants (Table 3).
The backbone of residues 213–217 becomes highly
mobile in response to the movement of V246. A216 and
V217 respond as noted above, and the peptide bond between
FIGURE 5 Average structures from the simulations of wt and D143A
TGT highlight the changes observed in many of the active site residues.
Large shifts are seen for guanine, S90, A216, V217, and V246. More mild
changes are seen in G213, L215, and M244. Wt is colored by atom type, and
D143A is in yellow.
FIGURE 6 Flexibility in the 213–217 region of E. coli TGT is seen in
the same region of Z. mobilis TGT (residues 229–233). The examples shown
are from crystal structures of Z. mobilis TGT with different ligands bound:
preQ0 (7-deaza-7-cyano-guanine) is shown in red (PDB code 1P0B, (53));
preQ1 (7-deaza-7-aminomethyl-guanine) is blue (PDB code 1P0E, (53));
3,5-diaminophthalhydrazide is green (PDB code 1F3E, (52)); 2-amino-
quinazolin-4(3H)-one is yellow (PDB code 1S39, (10)).
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G213 and G214 ﬂips its backbone by 90. Fig. 6 shows how
this same region in Z. mobilis TGT rearranges the backbone
in response to binding different heterocyclic ligands. Though
this region appears to have a higher degree of ﬂexibility than
one might expect, it inherently adapts to changes in the
binding site whether caused by mutation or binding different
ligands.
CONCLUSION
Our experimental studies have shown that E. coli D143-
mutant TGTs have reduced activity due to altered binding of
heterocycles with only a very minor reduction in catalysis
and no discernable effect on tRNA binding. Due to the
absolute conservation of this residue in TGTs across
kingdoms, it is reasonable to propose that D143 carries out
this role in all TGTs. We were surprised to ﬁnd that the
D143A mutant exhibited a higher afﬁnity for guanine than
D143N, D143S, and D143T. Hydrogen-bonding arguments
would imply that D143A have the poorest afﬁnity. To
understand this trend, we turned to computer models of TGT.
Our homology model gave us insight into the experimen-
tal results. The model was validated by its similarity to re-
lated systems and its ability to accurately reproduce free
energies of binding based on MD simulations. It was pos-
sible to ﬁt the van der Waals scaling factor, a, to the exper-
imental data yielding a value of 0.55; this value is well within
the literature established values of 0.1–1.2. The LIE method
has been successfully used throughout the literature to pre-
dict free energies of binding, generally to rank many ligands
binding to one receptor. It is important to note that this is one
of the few examples of the successful prediction of a single
ligand binding to multiple mutant enzymes.
Several patterns have been observed in the MD to explain
the differences in binding between the wt and mutant TGTs.
The high binding afﬁnity seen in the wt TGT is due to strong
hydrogen bonding and good electrostatics between guanine
and the charged side chain of D143. The unexpected low KM
value seen for D143A appears to be caused by several water
molecules entering the active site and providing bridging
hydrogen bonds between the ligand and binding site, thereby
compensating for lost protein-ligand interactions. The
reduced binding afﬁnity for the mutants (D143A . D143N
. D143S . D143T) appears to be due to lost hydrogen
bonds and poorer molecular recognition.
Many of the bridging water molecules are held in proper
orientation by D89, S90, and D264. The loss of the
carboxylate at D143 allows S90 and D89 to reorient and
play this important new role. Additional changes are also
observed in the conformation of D264 and M244-V246 that
allow for new binding motifs. Lastly, the backbone from
G213-V217 is highly mobile and adaptive. This is in agree-
ment with recent crystal structures of Z. mobilis TGT
(10,52,53).
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